Identification of STAT3-independent regulatory effects for protein inhibitor of activated STAT3 by binding to novel transcription factors

9Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Protein Inhibitor of Activated Signal Transducer and Activators of Transcription 3 (PIAS 3) is a molecule that regulates STAT3 and has antiproliferative properties. Glioblastoma and squamous cell lung cancer lack PIAS 3 expression. To test the hypothesis that PIAS 3 transcriptional effects are STAT3-independent, we developed models for STAT3 knockdown and PIAS 3 overexpression. PIAS 3 expression results in a distinct transcriptional profile that does not occur with STAT3 knockdown. We identify novel transcription factor binding partners for PIAS 3 including ETS, EGR1, NR1I2 and GATA1. PIAS 3 binds to these factors and regulates their transcriptional effects resulting in alterations in canonical pathways including Wnt/β-catenin signaling and functions such as cell death and proliferation. A model is proposed by which PIAS 3 effects EGR1 regulated pathways. © 2011 Landes Bioscience.

Cite

CITATION STYLE

APA

Dabir, S., Kluge, A., Aziz, M. A., Houghton, J. A., & Dowlati, A. (2011). Identification of STAT3-independent regulatory effects for protein inhibitor of activated STAT3 by binding to novel transcription factors. Cancer Biology and Therapy, 12(2), 139–151. https://doi.org/10.4161/cbt.12.2.15732

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free